Efficacy of mitoxantrone and etoposide in patients with acute myeloid leukemia refractory to initial standard induction therapy

被引：1
|
作者：
Sehgal, Rajesh [1 ]
McHayleh, Wassim [1 ]
Natale, James [1 ]
Raptis, Anastasios [1 ]
Agha, Mounzer [1 ]
Redner, Robert L. [1 ]
Richard, Gene [1 ]
Welsh, Ann [1 ]
Foon, Kenneth A. [1 ]
Boyiadzis, Michael [1 ]
机构：
[1] Univ Pittsburgh, Inst Canc, Dept Med, Div Hematol Oncol, Pittsburgh, PA 15260 USA
来源：
BLOOD | 2007年 / 110卷 / 11期
关键词：
D O I：
10.1182/blood.V110.11.4385.4385
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4385
引用
收藏
页码：164B / 164B
页数：1
相关论文
共 50 条
  • [1] EFFICACY OF ETOPOSIDE AND MITOXANTRONE IN PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA REFRACTORY TO STANDARD INDUCTION THERAPY AND INTERMEDIATE-DOSE CYTARABINE WITH AMSIDINE
    DAENEN, S
    LOWENBERG, B
    SONNEVELD, P
    VANPUTTEN, WLJ
    VERHOEF, G
    VANVELDHOVEN, M
    HUIJGENS, PC
    LEUKEMIA, 1994, 8 (01) : 6 - 10
  • [2] Mitoxantrone, etoposide, and cyclosporine therapy in pediatric patients with recurrent or refractory acute myeloid leukemia
    Dahl, GV
    Lacayo, NJ
    Brophy, N
    Dunussi-Joannopoulos, K
    Weinstein, HJ
    Chang, MR
    Sikic, BI
    Arceci, RJ
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (09) : 1867 - 1875
  • [3] Efficacy and safety of mitoxantrone, etoposide, and cytarabine for treatment of relapsed or refractory acute myeloid leukemia
    Zhong, Sharon
    Kurish, Heena
    Walchack, Robert
    Li, Hong
    Edwards, Jessi
    Singh, Abhay
    Advani, Anjali
    LEUKEMIA RESEARCH, 2024, 139
  • [4] COMBINATION THERAPY WITH MITOXANTRONE AND ETOPOSIDE IN REFRACTORY ACUTE MYELOGENOUS LEUKEMIA
    HO, AD
    LIPP, T
    EHNINGER, G
    MEYER, P
    FREUND, M
    HUNSTEIN, W
    CANCER TREATMENT REPORTS, 1986, 70 (08): : 1025 - 1027
  • [5] Gemtuzumab ozogamicin, mitoxantrone, and etoposide in newly diagnosed acute myeloid leukemia patients with persistent leukemia after a course of induction therapy
    Michael Boyiadzis
    Robert L. Redner
    Anastasios Raptis
    Jing-Zhou Hou
    Mounzer Agha
    Kenneth A. Foon
    Annals of Hematology, 2011, 90 : 733 - 735
  • [6] Etoposide and mitoxantrone in newly diagnosed acute myeloid leukemia patients with persistent leukemia after a course of induction therapy with cytarabine and idarubicin
    McHayleh, W. M.
    Redner, R.
    Sehgal, R.
    Raptis, A.
    Agha, M.
    Natale, J.
    Luong, T.
    Schlesselman, J. J.
    Foon, K.
    Boyiadzis, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [7] Gemtuzumab ozogamicin, mitoxantrone, and etoposide in newly diagnosed acute myeloid leukemia patients with persistent leukemia after a course of induction therapy
    Boyiadzis, Michael
    Redner, Robert L.
    Raptis, Anastasios
    Hou, Jing-Zhou
    Agha, Mounzer
    Foon, Kenneth A.
    ANNALS OF HEMATOLOGY, 2011, 90 (06) : 733 - 735
  • [8] Efficacy and safety of mitoxantrone and etoposide (ME) in refractory and relapsed acute nonlymphocytic leukemia
    Pourtsidis, AG
    Baka, M
    Stasinopoulou, A
    Varvoutsi, M
    Paidoussi, C
    Bouhoutsou, D
    Kosmidis, HV
    INTERNATIONAL JOURNAL OF PEDIATRIC HEMATOLOGY/ONCOLOGY, 1998, 5 (01): : 7 - 11
  • [9] Mitoxantrone and Etoposide for the Treatment of Acute Myeloid Leukemia Patients in First Relapse
    Im, Annie
    Amjad, Ali
    Agha, Mounzer
    Raptis, Anastasios
    Hou, Jing-Zhou
    Farah, Rafic
    Lim, Seah
    Sehgal, Alison
    Dorritie, Kathleen A.
    Redner, Robert L.
    McLaughlin, Brian
    Shuai, Yongli
    Duggal, Shrina
    Boyiadzis, Michael
    ONCOLOGY RESEARCH, 2016, 24 (02) : 73 - 80
  • [10] Mitoxantrone and etoposide for acute myeloid leukemia in first relapse
    Im, Annie P.
    McLaughlin, Brian Thomas
    Lin, Yan
    Raptis, Anastasios
    Agha, Mounzer E.
    Hou, Jing-Zhou
    Redner, Robert
    Boyiadzis, Michael
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
12345